CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
Product revenue	$ 385.0	$ 378.6	$ 1,119.9	$ 1,101.0
Service revenue	53.1	50.9	159.3	150.2
Other revenue	0.9	18.3	8.1	22.9
Total revenue	439.0	447.8	1,287.3	1,274.1
Cost of product revenue	208.6	206.8	610.9	596.5
Cost of service revenue	37.2	30.9	107.1	89.9
Total cost of revenue	245.8	237.7	718.0	686.4
Gross profit	193.2	210.1	569.3	587.7
Operating expenses:
Selling, general and administrative	105.7	102.4	319.6	316.4
Research and development	45.5	44.9	141.4	145.0
Other charges, net	10.5	2.5	21.1	9.5
Total operating expenses	161.7	149.8	482.1	470.9
Operating income	31.5	60.3	87.2	116.8
Interest and other income (expense), net	(4.7)	(2.7)	(16.4)	(13.0)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	26.8	57.6	70.8	103.8
Income tax provision	9.9	17.7	24.9	38.9
Consolidated net income	16.9	39.9	45.9	64.9
Net income attributable to noncontrolling interest in consolidated subsidiaries	0.3	0.2	1.0	0.2
Net income attributable to Bruker Corporation	16.6	39.7	44.9	64.7
Net income per common share attributable to Bruker Corporation shareholders:
Basic and diluted (in dollars per share)	$ 0.10	$ 0.24	$ 0.27	$ 0.39
Weighted average common shares outstanding:
Basic (in shares)	167.0	166.0	166.6	165.9
Diluted (in shares)	168.7	167.3	168.4	167.3
Comprehensive income	53.5	51.8	58.9	61.9
Less: Comprehensive income attributable to noncontrolling interests	0.3	0.1	1.0	0.2
Comprehensive income attributable to Bruker Corporation	$ 53.2	$ 51.7	$ 57.9	$ 61.7